Atlas Trials

Empagliflozin for No-reflow Phenomenon in PCI for STEMI

Clinical trial NCT06342141 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT06342141
Sponsor
Instituto Nacional de Cardiologia Ignacio Chavez
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
STEMINo-Reflow Phenomenon
Start date
2024-08-22
Primary completion
2026-03-15
Enrollment
162

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.